CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 558 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05419336
NCT05419336N/ACompleted

Child Growth and Development in East London

Queen Mary University of London·observational·Posted Jun 15, 2022·Updated May 20, 2025

In Brief

An observational study for Stunted Growth and 3 related conditions. Completed, enrolled 558 participants across 1 site.

Detailed Summary

The overarching objective of this research is to detect poor growth and delayed development early in childhood by developing an automated growth-screening algorithm. The screening algorithm will be created using cohort data and piloted for feasibility and acceptability in Tower Hamlets. The ultimate goals are to detect linear growth failure and delayed development early to identify two groups of children: first, children with serious underlying medical disorders, in whom earlier diagnosis and management would improve clinical outcomes; and second, children whose poor growth and/or delayed development is a manifestation of socioeconomic disadvantage, in whom targeted pre-school interventions may improve long term health and education outcomes.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited Kingdom

Timeline

N/ACompletedFinished
2023202420252026
First PostedJun 15, 2022
Enrollment StartJul 15, 2022
Primary CompletionMar 30, 2024
Study CompletionSep 30, 2024
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 4.0 years ago